Product Information
ATACAND 16 MG TABLET is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $7.8502 per EA under NDC 62559064290. Its NADAC has been published 232 times since May 22, 2019.
FDA first approved this application on Jun 4, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Candesartan Cilexetil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
16 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559064290
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
CANDESARTAN CILEXETILApproval Type
New Drug (NDA)
FDA Application
NDA020838FDA Approved
6/4/1998
TE Code
AB
On Market Since
10/1/2018
Pharmacological Classes
Price Statistics
The NADAC for ATACAND 16 MG TABLET has been published 232 times since May 22, 2019, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8502 per EA |
|---|---|
| All-time high | $7.9072 (Dec 11, 2024) |
| All-time low | $6.9063 (May 22, 2019) |
| 52-week high | $7.8831 |
| 52-week low | $7.8502 |
| Median price | $7.6671 |
| Average price | $7.5681 |
| Largest weekly change | +9.5% (Mar 4, 2020) |
| Weeks tracked | 232 |
| Tracking since | May 22, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATACAND 16 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATACAND 16 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $7.8502 per EA (NDC 62559064290), effective Aug 19, 2026.
How has the price of ATACAND 16 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATACAND 16 MG TABLET has risen 13.7%. It has been tracked across 232 weekly CMS publications since May 22, 2019.
What are the highest and lowest recorded NADAC prices for ATACAND 16 MG TABLET?
Since May 22, 2019, the NADAC for ATACAND 16 MG TABLET has ranged from a low of $6.9063 (May 22, 2019) to a high of $7.9072 (Dec 11, 2024), with a median of $7.6671 per EA.
Are there cheaper alternatives to ATACAND 16 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ATACAND 16 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ATACAND 16 MG TABLET?
ATACAND 16 MG TABLET (NDC 62559064290) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.